aTyr Pharma ATYR Total debt

Total debt at other companies

Bristol-Myers SquibbBMY

$43.33B-12.3%

Merck & Co.MRK

$56.73B+54.0%

Design Therapeutics, Inc.DSGN

$2.73M+27.7%

Oric Pharmaceuticals, Inc.ORIC

$3.3M+2.6%

Syndax PharmaceuticalsSNDX

$350.49M+4.2%

Stoke Therapeutics, Inc.STOK

$3.42M-42.5%

FAQ

What is aTyr Pharma's total debt?

aTyr Pharma (ATYR) reported total debt of $11.82M in Q2 2026.

How has aTyr Pharma's total debt changed year-over-year?

aTyr Pharma's total debt decreased by 10.7% year-over-year, from $13.24M to $11.82M.

What is the long-term trend for aTyr Pharma's total debt?

Over 5 years (2020 to 2025), aTyr Pharma's total debt has grown at a 41.4% compound annual growth rate (CAGR), from $2.24M to $12.66M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.